NIPH Clinical Trials Search

Basic Information

Recruitment status	completed
Health condition(s) or Problem(s) studied
Date of first enrollment	11/01/2018
Target sample size	3
Countries of recruitment	Japan,Asia except Japan,North America,South America,Europe
Study type	Interventional
Intervention(s)	investigational material(s) Generic name etc : INN of investigational material : Riociguat Therapeutic category code : 219 Other cardiovascular agents Dosage and Administration for Investigational material : control material(s) Generic name etc : INN of investigational material : Sildenafil,Tadalafil Therapeutic category code : 214 Antihypertensives Dosage and Administration for Investigational material :

Outcome(s)

Primary Outcome	efficacy
Secondary Outcome	safety efficacy

Key inclusion & exclusion criteria

Age minimum	>= 18age old
Age maximum	<= 75age old
Gender	Both
Include criteria
Exclude criteria